Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $1.40 billion. The enterprise value is $974.30 million.
Important Dates
The next estimated earnings date is Thursday, February 13, 2025, after market close.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NRIX has 70.84 million shares outstanding. The number of shares has increased by 13.03% in one year.
| Current Share Class | 70.84M |
| Shares Outstanding | 70.84M |
| Shares Change (YoY) | +13.03% |
| Shares Change (QoQ) | +16.68% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 93.62% |
| Float | 57.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.51 |
| Forward PS | 23.18 |
| PB Ratio | 3.53 |
| P/TBV Ratio | 3.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.28 |
| Quick Ratio | 5.20 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.96% and return on invested capital (ROIC) is -37.49%.
| Return on Equity (ROE) | -57.96% |
| Return on Assets (ROA) | -29.46% |
| Return on Capital (ROIC) | -37.49% |
| Revenue Per Employee | $198,676 |
| Profits Per Employee | -$623,155 |
| Employee Count | 284 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $262,000 in taxes.
| Income Tax | 262,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +99.70% in the last 52 weeks. The beta is 2.11, so NRIX's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | +99.70% |
| 50-Day Moving Average | 23.51 |
| 200-Day Moving Average | 19.94 |
| Relative Strength Index (RSI) | 38.42 |
| Average Volume (20 Days) | 988,449 |
Short Selling Information
The latest short interest is 9.35 million, so 13.20% of the outstanding shares have been sold short.
| Short Interest | 9.35M |
| Short Previous Month | 9.60M |
| Short % of Shares Out | 13.20% |
| Short % of Float | 16.19% |
| Short Ratio (days to cover) | 9.08 |
Income Statement
In the last 12 months, NRIX had revenue of $56.42 million and -$176.98 million in losses. Loss per share was -$2.89.
| Revenue | 56.42M |
| Gross Profit | -147.70M |
| Operating Income | -193.70M |
| Pretax Income | -164.82M |
| Net Income | -176.98M |
| EBITDA | -186.40M |
| EBIT | -193.70M |
| Loss Per Share | -$2.89 |
Full Income StatementBalance Sheet
The company has $448.05 million in cash and $27.14 million in debt, giving a net cash position of $430.38 million or $6.08 per share.
| Cash & Cash Equivalents | 448.05M |
| Total Debt | 27.14M |
| Net Cash | 430.38M |
| Net Cash Per Share | $6.08 |
| Equity (Book Value) | 376.86M |
| Book Value Per Share | 5.62 |
| Working Capital | 369.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$97.14 million and capital expenditures -$9.75 million, giving a free cash flow of -$106.90 million.
| Operating Cash Flow | -97.14M |
| Capital Expenditures | -9.75M |
| Free Cash Flow | -106.90M |
| FCF Per Share | -$1.51 |
Full Cash Flow StatementMargins
| Gross Margin | -261.76% |
| Operating Margin | -343.30% |
| Pretax Margin | -313.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.03% |
| Shareholder Yield | -13.03% |
| Earnings Yield | -12.60% |
| FCF Yield | -7.61% |
Analyst Forecast
The average price target for NRIX is $30.29, which is 52.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.29 |
| Price Target Difference | 52.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 33.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 1.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.05 |
| Piotroski F-Score | 2 |